Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
Aoife Ward(German Cancer Research Center), Özgür Şahin(Medical University of South Carolina)
Cited by 286
Related Papers
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer
|Oncotarget|2016|59
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
|Breast Cancer Research and Treatment|2022|58